Related Experiment Video
Updated: Jan 22, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish
Cyntia B Manzano-Salgado1, Berit Granum2, Maria-Jose Lopez-Espinosa3
1ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain.
Insights
Prenatal exposure to per- and polyfluoroalkyl substances (PFASs) showed varied effects on child health. Some PFASs like PFNA and PFOS may reduce asthma and eczema risks, while PFOA exposure was linked to reduced lung function in early childhood.
Area of Science:
- Environmental Health
- Pediatric Health
- Toxicology
Background:
- Prenatal exposure to perfluoroalkyl substances (PFASs) is linked to childhood immune and respiratory issues, but evidence on lung function is inconsistent.
- The Spanish INMA birth cohort study investigated these associations up to age 7.
Purpose of the Study:
- To examine the association between prenatal exposure to specific PFASs and immune/respiratory health, including lung function, in children.
- To differentiate the effects of various PFAS compounds on developing children's health.
Main Methods:
- Assessed four PFASs (PFHxS, PFOS, PFOA, PFNA) in maternal plasma from early pregnancy.
- Collected data on respiratory infections, wheezing, asthma, and eczema up to age 7.
- Measured lung function using spirometry at ages 4 and 7.
Main Results:
- Higher PFNA concentrations were associated with a reduced risk of childhood asthma (RR 0.74).
- Higher PFOS concentrations were linked to a reduced risk of childhood eczema (RR 0.86).
- Elevated PFOA exposure correlated with lower lung function (forced vital capacity and FEV1) at age 4, but not at age 7.
Conclusions:
- Different PFASs appear to impact developing immune and respiratory systems uniquely.
- Prenatal PFNA and PFOS exposure may lower risks for asthma and eczema, whereas PFOA exposure might impair early lung function.
- Further longitudinal studies are needed to confirm these findings at later ages.
Background:
Prenatal exposure to perfluoroalkyl substances (PFASs) has been associated with impaired immune and respiratory health during childhood but the evidence is inconsistent and limited for lung function. We studied the association between prenatal PFASs exposure and immune and respiratory health, including lung function, up to age 7 years in the Spanish INMA birth cohort study.
Methods:
We assessed four PFASs in maternal plasma samples collected during the 1st trimester of pregnancy (years: 2003-2008): perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), and perfluorononanoate (PFNA). Mothers reported the occurrence (yes/no) of lower respiratory tract infections, wheezing, asthma, and eczema in the previous 12 months at 1.5 and 4 years of the child (n = 1188) and at 7 years (n = 1071). At ages 4 (n = 503) and 7 (n = 992) years lung function was assessed using spirometry tests.
Results:
The most abundant PFASs were PFOS and PFOA (geometric means: 5.80 and 2.31 ng/mL, respectively). The relative risk of asthma during childhood per each doubling in PFNA concentration was 0.74 (95 CI%: 0.57, 0.96). The relative risk of eczema during childhood per every doubling in PFOS concentration was 0.86 (95 CI%: 0.75, 0.98). Higher PFOA concentrations were associated with lower forced vital capacity and lower forced expiratory volume in 1 s z-scores at 4 years [β (95 CI %): -0.17 (-0.34, -0.01) and -0.13 (-0.29, 0.03), respectively], but not at 7 years.
Conclusion:
This longitudinal study suggests that different PFASs may affect the developing immune and respiratory systems differently. Prenatal exposure to PFNA and PFOS may be associated with reduced risk of respiratory and immune outcomes, particularly asthma and eczema whereas exposure to PFOA may be associated with reduced lung function in young children. These mixed results need to be replicated in follow-up studies at later ages.
Related Concept Videos
Birth Control Methods
Functions of the Lymphatic and Immune System
The primary lymphoid organs, including the bone marrow and the thymus, serve as the maturation sites for lymphocytes. Secondary lymphoid organs, like the mucosa-associated lymphoid tissue, activate these lymphocytes and serve as...
What is the Immune System?
Deleterious Substances in Aggregate
Another type of impurity is clay and fine material that...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Lung Capacity

